Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC9034 | Atomoxetine HCl |
Atomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively).
More description
|
![]() |
DC11076 | Ampreloxetine |
Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively.
More description
|
![]() |
DC8605 | Alvimopan dihydrate |
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
More description
|
![]() |
DC8606 | Alvimopan monohydrate |
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery.
More description
|
![]() |
DC11525 | Mocravimod |
A synthetic immunosuppressant that functions as a S1P1 receptor agonist.
More description
|
![]() |
DC11519 | Ceclazepide |
A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD)..
More description
|
![]() |
DC11546 | Azeloprazole sodium |
A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
More description
|
![]() |
DC11515 | Azeloprazole |
A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
More description
|
![]() |
DCE-016 | Chenodeoxycholic acid |
>98%,Standard References
More description
|
![]() |
DC9450 | (R)-Baclofen |
(R)-Baclofen(STX209) is a selective GABAB receptor agonist.
More description
|
![]() |